Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN9A | Q15858 | 15/20 | 0.47 |
| ▸ | SCN10A | Q9Y5Y9 | 2/20 | 0.45 |
| ▸ | ALOX5AP | P20292 | 2/20 | 0.39 |
| ▸ | FEN1 | P39748 | 2/20 | 0.39 |
| ▸ | ITK | Q08881 | 1/20 | 0.38 |
| ▸ | FABP3 | P05413 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6507532 | 0.92 | SCN9A (0.52) | SCN9ASCN10AALOX5APFEN1ITK | |
| SCHEMBL6470117 | 0.91 | ALOX5AP (0.39) | SCN9ASCN10AALOX5APFEN1ITK | |
| SCHEMBL6469640 | 0.84 | ALOX5AP (0.41) | SCN9AALOX5APFEN1ITKKDM4E | |
| SCHEMBL6465874 | 0.84 | ITK (0.44) | SCN9AITKKDM4EALDH1A1HTT | |
| SCHEMBL6465917 | 0.83 | ITK (0.41) | SCN9AALOX5APFEN1ITK | |
| SCHEMBL6470662 | 0.82 | ITK (0.45) | SCN9AITKKDM4EMEN1ALDH1A1 | |
| SCHEMBL6470404 | 0.82 | GPBAR1 (0.37) | SCN9AALOX5APFEN1ITKALDH1A1 | |
| SCHEMBL6498000 | 0.82 | ALOX5AP (0.39) | SCN9AALOX5APFEN1ITKKDM4E | |
| SCHEMBL6470295 | 0.82 | SCN9A (0.49) | SCN9ASCN10AITKKDM4EMEN1 | |
| SCHEMBL6467409 | 0.81 | FEN1 (0.48) | SCN9AALOX5APFEN1ITK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050197338-A1 | Substituted pyrazole urea compounds for the treatment of inflammation | PHARMACIA AND UPJOHN COMPANY LLC | 2005-09-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050197338-A1 | Substituted pyrazole urea compounds for the treatment of inflammation | IL4, ARG2, CASP4 | SCN9A 4159/4885SCN10A 3527/4885ALOX5AP 3501/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.